Skip to main content
ACR Convergence 2023 Main banner
Final Program


Schedule at a Glance
Legend
Session Format
In Person
In Person
Livestreamed
Livestreamed
On Demand
On Demand
Back

Scientific Session

Systemic lupus erythematosus (SLE)

Session: Lupus Prevention and Disease-Modifying Anti-Lupus Drugs (DMALDs), Are We There Yet?

Can Current Lupus Treatments Be Classified as DMALDs?

Sunday, November 12, 2023
9:30 AM – 9:45 AM PT
Location: Room 11A-B
In Person On Demand

    Speaker(s)

  • AA

    Anca Askanase, MD, MPH

    Director
    Columbia University Medical Center
    New York, NY, United States

    Disclosure(s): Amgen: Data Safety Monitoring Board (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing); Bristol-Myers Squibb(BMS): Clinical Trial Steering Committee (Ongoing); Genentech: Investigator in clinical trail (Ongoing); GlaxoSmithKlein(GSK): Advisor or Review Panel Member (Ongoing); Idorsia: Lead PI for clinical trial (Ongoing); Sanofi: Lead PI clinical trial (Ongoing)